VRTX
$VRTX
Vertex Pharmaceuticals
Biotech leader in cystic fibrosis treatments and pain therapies.
Healthcare$458.99
+5.82 (+1.28%)
Day Range$447.54 - $464.31
Prev Close$453.17
Analyst Rating
Strong Buy
33 Buy / 6 Hold / 1 Sell
Subscribers
0
Tracking this ticker
Next Report
—
Weekly updates
Latest Report
This week's analysis
VRTX: Pipeline Strength and Upside to Analyst Targets
Vertex ($VRTX) remains a market leader in cystic fibrosis with expanding pipeline catalysts and strong fundamentals. Analysts are bullish with a mean target implying ~23% upside heading into Q2 results.
Jun 14, 2026